Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Miller Receives Biomaterials Award for Celiac Disease Nanoparticle Therapy
Campus News

Miller Receives Biomaterials Award for Celiac Disease Nanoparticle Therapy

By Will DossApr 12, 2021
Share
Facebook Twitter Email
Stephen Miller, PhD, the Judy Gugenheim Research Professor of Microbiology-Immunology, received the 2021 Technology Innovation and Development Award from the Society For Biomaterials (SFB).

Stephen Miller, PhD, the Judy Gugenheim Research Professor of Microbiology-Immunology, has received the 2021 Technology Innovation and Development Award from the Society For Biomaterials (SFB).

Miller is among a group of scientists who designed and tested nanoparticles that induce gluten tolerance in celiac disease, findings that were published in the journal Gastroenterology.

“The study is the first demonstration that immune tolerance to gluten can be induced in humans with celiac using a ‘negative vaccine’ consisting of gluten encapsulated within nanoparticles which induces a regulatory immune response,” said Miller, who is also a professor of Dermatology, of Medicine in the Division of Gastroenterology and Hepatology and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

About 1 percent of the population has celiac disease, a serious autoimmune disease in which the ingestion of gluten leads to damage in the small intestine. When people with celiac disease eat gluten — a protein found in wheat — their body mounts an immune response that attacks the small intestine.

Miller and his colleagues designed a biodegradable nanoparticle containing gluten that teaches the immune system that gluten is safe. The nanoparticle acts like a Trojan horse, hiding the allergen in a friendly shell to convince the immune system not to attack it.

After treatment with the technology, patients in the trial were able to eat gluten with a substantial reduction in inflammation, while patients in the untreated control group developed inflammation in the small intestine that is a characteristic of celiac disease.

Currently, there is no treatment for celiac disease, and doctors can only recommend gluten avoidance. This nanoparticle platform could be the key to a long-awaited treatment, not just for celiac disease but for other autoimmune and allergic diseases as well, according to Miller.

“Traditional treatments for autoimmune disease employ immunosuppressive drugs which lack specificity and make patients highly susceptible to infections and increase rates of cancer,” Miller said. “The clinical trial proved that the gluten-containing nanoparticles were safe and highly efficacious.”

The study was sponsored by COUR Pharmaceuticals Development and supported by Takeda Pharmaceuticals International.

The SFB is a multidisciplinary society of academic, healthcare, governmental and business professionals dedicated to promoting advancements in all aspects of biomaterial science, education and professional standards to enhance human health and quality of life.

Awards Faculty Gastroenterology Immunology Research
Share. Facebook Twitter Email

Related Posts

Dissolving Implantable Device Relieves Pain Without Drugs

Jun 30, 2022

Fathers’ Presence During Childhood Predicts Adult Testosterone Levels

Jun 29, 2022

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Comments are closed.

Latest News

Physician Assistant Students Embrace ‘Shades of Purple’

Jul 1, 2022

Dissolving Implantable Device Relieves Pain Without Drugs

Jun 30, 2022

Fathers’ Presence During Childhood Predicts Adult Testosterone Levels

Jun 29, 2022

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220617_NM_0434
20220617_NM_0858
20220617_NM_0643
20220617_NM_0835
20220617_NM_0544
20220617_NM_0450
20220617_NM_0790
20220617_NM_0811
20220617_NM_0851
20220617_NM_0696
20220617_NM_0779
20220617_NM_0838

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.